Financial Data and Key Metrics Changes - Sales for the quarter were $983 million, representing a 2% increase in local currency and a 4% increase on a U.S. dollar reported basis [11] - Adjusted EPS for the quarter was $10.9, a 5% increase over the prior year [15] - Gross margin was 59%, a decrease of 70 basis points due to tariff costs and lower volume [13] Business Line Data and Key Metrics Changes - Laboratory sales increased by 1%, while industrial sales increased by 4%, with core industrial up 2% and product inspection up 8% [12] - Food retail sales were flat for the quarter [28] - Service business grew by 4% in the quarter and 5% year-to-date [30] Market Data and Key Metrics Changes - Local currency sales increased by 3% in The Americas, were flat in Europe, and increased by 3% in Asia Rest of the World [12] - Local currency sales in China declined by 2% during the quarter [12] Company Strategy and Development Direction - The company is focused on leveraging its innovative product portfolio and strategic programs to navigate uncertain market conditions [8] - There is an emphasis on capitalizing on onshoring investments and the demand for automation and productivity solutions [27][32] - The company anticipates growth opportunities from the replacement cycle of aging equipment as market conditions stabilize [34] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in mitigating tariff impacts and expects to fully offset these costs next year [10][20] - The outlook for the second half of the year remains cautious, with expectations of stable demand in China and mixed conditions in the laboratory sector [44] - Management noted that geopolitical tensions and trade disputes continue to create uncertainty in the market [20] Other Important Information - The company expects local currency sales to grow approximately 3% to 4% for the full year 2025 [21] - Adjusted EPS guidance for 2025 is in the range of $10.55 to $10.75, reflecting a growth rate of 3% to 5% [22] - The effective tax rate is expected to remain at 19% for 2025 [24] Q&A Session Summary Question: Impact of Swiss tariffs on EPS guidance - Management indicated that the gross headwind from the Swiss tariffs is approximately $0.40, and they are working on mitigation actions for next year [36][38] Question: Demand visibility in China - Management noted that while there is some stabilization, underlying market conditions remain soft, and they have not factored in potential stimulus [40][45] Question: Strength in product inspection - Management highlighted that new product innovations have led to market share gains and they expect continued growth in this segment [48][51] Question: Service business timing issues - Management explained that timing issues in Q2 were project-related, but they remain optimistic about growth in the second half of the year [75][78] Question: Replacement cycle dynamics - Management discussed pent-up demand for equipment replacement and indicated that while there may not be a snapback, there will be an acceleration as market confidence returns [99][101]

Financial Data and Key Metrics Changes - Sales for the quarter were $983 million, representing a 2% increase in local currency and a 4% increase on a U.S. dollar reported basis [11] - Adjusted EPS for the quarter was $10.9, a 5% increase over the prior year, while reported EPS was $9.76 compared to $10.37 in the prior year [15][16] - Gross margin was 59%, a decrease of 70 basis points due to tariff costs and lower volume [13] - Adjusted operating profit was $283.3 million, flat versus the prior year, with an adjusted operating margin of 28.8%, down 120 basis points [14] Business Line Data and Key Metrics Changes - Laboratory sales increased by 1%, while industrial sales increased by 4%, with core industrial up 2% and product inspection up 8% [12] - Food retail sales were flat for the quarter [28] - The service business grew by 4% in the quarter and 5% year-to-date [31] Market Data and Key Metrics Changes - Local currency sales increased by 3% in The Americas, were flat in Europe, and increased by 3% in Asia Rest of the World [12] - Local currency sales in China declined by 2% during the quarter [12] Company Strategy and Development Direction - The company is focused on mitigating the impact of tariffs and is confident in its ability to offset these costs in the future [9][20] - The company is well-positioned to benefit from increased investments in automation and productivity solutions, particularly in the context of onshoring trends [33][34] - The company anticipates a return to normal replacement cycles for lab equipment, indicating pent-up demand for upgrades [35][102] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating uncertain market conditions and highlighted the importance of their innovative product portfolio [7][9] - The outlook for the second half of the year remains cautious, with expectations of flat sales in China and mixed conditions in Europe [31][46] - Management noted that geopolitical tensions and tariff dynamics could continue to impact operations, but they are optimistic about future growth opportunities [20][35] Other Important Information - The company expects local currency sales to grow approximately 3% to 4% for the full year 2025, with adjusted EPS guidance revised to a range of $10.55 to $10.75 [22][23] - Incremental global tariff costs are estimated at approximately $95 million on an annualized basis, down from previous estimates [19] Q&A Session Summary Question: EPS guidance and offset activities - Management indicated that the $0.40 lower EPS guidance reflects the gross headwind from tariffs, with ongoing mitigation efforts planned for the next year [38][40] Question: Demand visibility in China - Management noted that while there is stability in overall volume, underlying market conditions in China remain soft, and no significant changes are expected [42][46] Question: Strength in product inspection - Management highlighted that recent innovations and a refreshed product portfolio have led to market share gains in product inspection, with expectations for continued growth [51][54] Question: Service business timing issues - Management explained that timing issues in Q2 were project-related, but they remain optimistic about returning to growth in the service business in the second half of the year [78][80] Question: Replacement cycle dynamics - Management discussed pent-up demand for equipment replacements, indicating that while there may not be a snapback, a gradual return to normal replacement cycles is expected as market conditions stabilize [102][105]

Financial Performance - Q2 2025 - Mettler Toledo's Q2 2025 sales increased by 4% to $983221000 compared to $946750000 in Q2 2024[24] - Local currency sales growth was 2% in Q2 2025[7, 12, 18, 24] - Adjusted EPS increased by 5% to $1009 in Q2 2025, compared to $965 in Q2 2024[7, 24] - Adjusted operating margin decreased by 120 basis points to 288% in Q2 2025[7, 24] Financial Performance - YTD 2025 - Year-to-date net sales decreased by 0% to $1866965000 compared to $1872699000 in YTD 2024[25] - Year-to-date local currency sales growth was 0%[15, 22, 25] - Adjusted EPS decreased by 1% to $1827 year-to-date[25] - Adjusted operating margin decreased by 150 basis points to 279% year-to-date[25] Sales by Geography - Q2 2025 - Americas sales increased to $414000000 with 3% local currency growth[12] - Europe sales decreased to $274000000 with 0% local currency growth[12] - Asia/ROW sales increased to $295000000 with 3% local currency growth[12] Sales by Product - Q2 2025 - Laboratory product sales increased to $538000000 with 1% local currency growth[18] - Industrial product sales increased to $395000000 with 4% local currency growth[18]

Company Performance - Mettler-Toledo reported quarterly earnings of $10.09 per share, exceeding the Zacks Consensus Estimate of $9.58 per share, and showing an increase from $9.65 per share a year ago, representing an earnings surprise of +5.32% [1] - The company achieved revenues of $983.22 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.67% and increasing from $946.75 million year-over-year [2] - Over the last four quarters, Mettler-Toledo has consistently surpassed consensus EPS and revenue estimates [2] Stock Outlook - Mettler-Toledo shares have increased approximately 3.5% since the beginning of the year, while the S&P 500 has gained 8.2% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $10.57, with expected revenues of $987.38 million, and for the current fiscal year, the EPS estimate is $41.55 on revenues of $3.93 billion [7] Industry Context - The Medical - Instruments industry, to which Mettler-Toledo belongs, is currently ranked in the bottom 40% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

FOR IMMEDIATE RELEASE Exhibit 99.1 METTLER-TOLEDO INTERNATIONAL INC. REPORTS SECOND QUARTER 2025 RESULTS COLUMBUS, Ohio, USA – July 31, 2025 – Mettler-Toledo International Inc. (NYSE: MTD) today announced second quarter results for 2025. Provided below are the highlights: Second Quarter Results Six Month Results GAAP Results EPS was $17.56, compared with the prior-year amount of $18.60 which included a one-time non-cash tax benefit of $1.07 per share. Patrick Kaltenbach, President and Chief Executive Office ...

Group 1 - Mettler-Toledo (MTD) is expected to report quarterly earnings of $9.58 per share, a decline of 0.7% year-over-year, with revenues forecasted at $957.64 million, reflecting a 1.1% increase [1] - The consensus EPS estimate for the quarter has remained unchanged over the past 30 days, indicating analysts' reassessment of their initial projections [1] - Analysts project 'Net Sales- Products' to be $726.47 million, showing a year-over-year increase of 2% [4] Group 2 - 'Net Sales- Service (Point in Time+Over Time)' is estimated to reach $229.94 million, indicating a decline of 1.9% year-over-year [4] - 'Net Sales- Retail' is expected to be $47.83 million, reflecting a decrease of 2.9% compared to the previous year [4] - 'Net Sales- Industrial' is projected at $384.01 million, representing a year-over-year increase of 2.6% [5] Group 3 - 'Net Sales- Laboratory' is anticipated to be $529.10 million, indicating a 1.1% increase from the prior-year quarter [5] - Mettler-Toledo shares have recorded a return of 7.4% over the past month, outperforming the Zacks S&P 500 composite's 3.6% change [5] - Based on its Zacks Rank 3 (Hold), Mettler-Toledo is expected to perform in line with the overall market in the upcoming period [5]

Market Overview - The U.S. markets have shown an upward trend, with the S&P 500 and Nasdaq Composite reaching all-time highs, increasing by 1.32% and 0.64% respectively last week [1] - Positive corporate earnings and expectations of easing tariffs and trade policies have bolstered investor confidence [1] - Concerns over inflation and signs of a potential economic slowdown are influencing the Federal Reserve's cautious stance on interest rates [1] Economic Indicators - The Conference Board's Leading Economic Indicator fell by 0.3% in June, indicating early signs of a slowdown, with weakened consumer expectations and fewer manufacturing orders [2] - The S&P Global's U.S. flash PMI data for July indicated an acceleration in business activity driven by the services sector, while the manufacturing PMI dropped to 49.5 [2] - Initial jobless claims decreased by 4,000 to 217,000 for the week ending July 19, suggesting a resilient labor market with limited layoffs [2] Stock Performance - AngloGold Ashanti plc's shares increased by 23.1% since its upgrade to Zacks Rank 1 on May 19, outperforming the S&P 500's 7.2% increase [3][4] - NN Group N.V. saw a return of 12.1% since its upgrade to Zacks Rank 1 on May 29, compared to the S&P 500's 8.4% increase [4] - Zacks Rank 1 stocks returned +6.51% in May 2025, outperforming the S&P 500's +4.47% [5] Portfolio Performance - A hypothetical portfolio of Zacks Rank 1 stocks has outperformed the S&P 500 index by more than 12 percentage points since 1988 [6] - The Zacks Focus List portfolio returned +8.84% in 2025 (through June 30) compared to +6.21% for the S&P 500 [14] - The Zacks Earnings Certain Admiral Portfolio (ECAP) returned +3.20% in Q1 2025, outperforming the S&P 500's -4.30% decline [18] Notable Stocks - Intellia Therapeutics, Inc. gained 60.3% over the past 12 weeks, while Caterpillar Inc. returned 41.3% in the same period [13][14] - OptimizeRx Corporation and Artisan Partners Asset Management saw increases of 18.2% and 14.6% respectively since their upgrades to Outperform [10] - Hershey Company returned 17.8% over the past 12 weeks, benefiting from investor interest in quality dividend stocks [20]

Core Viewpoint - The market anticipates a year-over-year decline in Mettler-Toledo's earnings despite an increase in revenues for the quarter ending June 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Mettler-Toledo is expected to report quarterly earnings of $9.58 per share, reflecting a -0.7% change year-over-year, while revenues are projected to be $957.64 million, up 1.2% from the previous year [3]. - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. Earnings Surprise Potential - The Most Accurate Estimate for Mettler-Toledo is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +0.94%, suggesting a likelihood of beating the consensus EPS estimate [12]. - The company has a Zacks Rank of 3, indicating a hold position, which combined with the positive Earnings ESP suggests a potential earnings beat [12]. Historical Performance - Mettler-Toledo has consistently beaten consensus EPS estimates in the past four quarters, with the last reported quarter showing an earnings surprise of +3.67% [13][14]. Industry Context - In the same industry, Penumbra is expected to report earnings of $0.81 per share for the quarter ending June 2025, representing a +26.6% year-over-year change, with revenues projected at $327.85 million, up 9.5% [18]. - Penumbra also shows a positive Earnings ESP of +1.28% and has a Zacks Rank of 3, indicating a strong likelihood of beating consensus EPS estimates [19].

Group 1 - Mettler-Toledo (MTD) is positioned to maintain its earnings-beat streak, particularly in the upcoming report, with a history of surpassing earnings estimates [1][5] - The company reported earnings of $7.9 per share for the most recent quarter, missing the expectation of $8.19 per share, resulting in a surprise of 3.67% [2] - In the previous quarter, Mettler-Toledo exceeded the consensus estimate of $11.69 per share by reporting $12.41 per share, achieving a surprise of 6.16% [2] Group 2 - Estimates for Mettler-Toledo have been trending higher, supported by its earnings surprise history, and it has a positive Zacks Earnings ESP of +0.94% [5][8] - The combination of a positive Earnings ESP and a Zacks Rank 3 (Hold) suggests a high likelihood of another earnings beat, with historical data indicating a nearly 70% success rate for stocks with this combination [6][8] - The next earnings report for Mettler-Toledo is expected to be released on July 31, 2025 [8]

Market Overview - The three major U.S. stock indexes closed lower last week, with the Dow Jones Industrial Average down 1%, the S&P 500 down 0.3%, and the Nasdaq Composite down 0.1% [1] - The market pullback was influenced by renewed U.S. tariff threats, particularly higher levies on Canada and the European Union, raising concerns about economic growth and inflation [2] Earnings Performance - Despite tariff concerns, many investors focused on strong earnings reports from airlines and consumer stocks, indicating a resilient economy [2] - The second-quarter earnings season is critical for assessing the impact of tariffs on corporate profits [3] Zacks Research Performance - Mogo Inc. shares surged 81.8% since being upgraded to Zacks Rank 2 (Buy) on May 8, significantly outperforming the S&P 500's 11.1% increase [4] - ATI Inc. also saw a 32.6% return since its upgrade to Zacks Rank 2 on May 6, compared to the S&P 500's 10.7% increase [5] - A hypothetical portfolio of Zacks Rank 1 (Strong Buy) stocks returned +6.51% in May 2025, outperforming the S&P 500's +4.47% [5] Zacks Recommendations - Amarin Corporation and European Wax Center shares increased by 62.6% and 49.9%, respectively, after being upgraded to Outperform on May 12, against the S&P 500's 10.5% rise [8] - The Zacks Focus List portfolio returned 8.84% in 2025 (through June 30) compared to the S&P 500's +6.21% [12] Portfolio Performance - The Zacks Earnings Certain Admiral Portfolio (ECAP) returned +3.20% in Q1 2025, outperforming the S&P 500's -4.30% decline [16] - The Zacks Earnings Certain Dividend Portfolio (ECDP) returned +5.74% in Q1 2025, compared to the S&P 500's -2.41% [20] - The Zacks Top 10 Stocks portfolio delivered +11.8% year-to-date through June 2025, outperforming the S&P 500's +6.2% [22] Long-term Performance - Since 2004, the Zacks Focus List portfolio has produced an annualized return of +11.60%, compared to +10.22% for the S&P 500 [15] - The Top 10 portfolio has generated a cumulative return of +2,246.8% since 2012, significantly outperforming the S&P 500's +502.3% [24]